Themis Medicare share price
You have to be logged in to add this to Watchlist.- ₹82.13(0.95%)March 11, 2026 13:12:08 PM IST
- NSE
- BSE
- Vol : 58.44 K (NSE + BSE)Last 20 day avg : 96.47 K
Themis Medicare is trading 0.95% upper at Rs 82.13 as compared to its last closing price. Themis Medicare has been trading in the price range of 84.54 & 82.00. Themis Medicare has given -18.78% in this year & -1.15% in the last 5 days. The company posted a net profit of 10.09 Crores in its last quarter.Listed peers of Themis Medicare include Aurobindo Pharma (1.99%), Neuland Laboratories (2.56%), Pfizer (-2.02%).The Mutual Fund holding in Themis Medicare was at -% in . The MF holding has - from the last quarter. The FII holding in Themis Medicare was at 0.05% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 11, 2026, 07:45 AM UTC
- BetaHigh volatility1.31Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.21The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.65Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.76The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Bullish | 1,311.50 | 1.99 | 75,985.99 | 20.15 | 2.15 | 0.33 | 5.52 |
| Neuland Laboratories | Bearish | 12,915.95 | 2.56 | 16,541.66 | 92.96 | 12.69 | 0.08 | 7.17 |
| Pfizer | Bearish | 4,721.50 | -2.02 | 21,666.56 | 36.12 | 5.46 | 0.69 | 1.60 |
| Unichem Laboratories | Bearish | 330.00 | 2.17 | 2,326.64 | 23.18 | 1.29 | - | 3.51 |
| Jagsonpal Pharmaceuticals | Neutral | 180.65 | 2.12 | 1,208.37 | 33.88 | 5.54 | 1.25 | 3.18 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-13 | Quarterly Results & issue of Warrants |
| 2025-11-13 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
- IndustryMajor Drugs
- ISININE083B01024
- BSE Code530199
- NSE CodeTHEMISMED
Themis Medicare is trading at 82.13 as on Wed Mar 11 2026 07:42:08. This is 0.95% upper as compared to its previous closing price of 81.36.
The market capitalization of Themis Medicare is 754.84 Cr as on Wed Mar 11 2026 07:42:08.
The 52 wk high for Themis Medicare is 179.25 whereas the 52 wk low is 73.79
Themis Medicare can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 23.45
- Dividend Yield: 0.61%
- D/E ratio: -
Themis Medicare reported a net profit of 29.83 Cr in 2025.